Korean J Otorhinolaryngol-Head Neck Surg.  2008 May;51(5):429-434.

Results of Endoscopic Transnasal Transsphenoidal Treatment of Prolactin Secreting Pituitary Adenoma

Affiliations
  • 1Department of Otolaryngology-HNS, Collage of Medicine, The Catholic University of Korea, Seoul, Korea. entcho@catholic.ac.kr

Abstract

BACKGROUND AND OBJECTIVES: The endoscopic transnasal transsphenoidal approach is a common approach for pituitary tumor. The objectives of our study is to report indication, efficacy, safety and endocrine result of endoscopic transnasal transsphenoidal surgery in patients with prolactin secreting pituitary adenoma.
SUBJECTS AND METHOD
We retrospectively reviewed the medical records of 10 patients who had received endoscopic transnasal transsphenoidal pituitary surgery of prolactin secreting pituitary adenoma.
RESULTS
Three patients were resistant and intolerant in medical therapy. Visual symptoms were developed in 8 patients. Postoperatively, 4 patients (40%) achieved normalization of prolactin and relief of symptoms from endoscopic surgery alone. Four of the remaining 6 patients achieved postoperative normalization of prolactin with medication. Visual symptom was improved in all patients. One patient had postoperative diabetes insipidus.
CONCLUSION
We believe that the endoscopic method is a safe, hardly invasive and efficient surgical technique in prolactinoma. Medical treatment with dopamine agonist drugs is the mainstay of treatment and endoscopic surgery will be used in cases of drug resistance, intolerance and development of acute visual symptom, we may offer endoscopic surgery as a viable treatment option.

Keyword

Endoscope; Prolactin; Pituitary adenoma

MeSH Terms

Dopamine Agonists
Drug Resistance
Endoscopes
Humans
Medical Records
Pituitary Neoplasms
Prolactin
Prolactinoma
Retrospective Studies
Dopamine Agonists
Prolactin
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr